Prévention And NotR. Yee
List of bibliographic references
Number of relevant bibliographic references: 18.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000022 | Sarah Koch [Allemagne, Canada] ; Michael Cassel [Allemagne] ; Karsten Linne [Allemagne] ; Frank Mayer [Allemagne] ; Jürgen Scharhag [Allemagne] | ECG and echocardiographic findings in 10-15-year-old elite athletes |
| 000046 | Hong-Lei Li [République populaire de Chine] ; Shen-Ji Lu [République populaire de Chine] ; Yi-Min Sun [République populaire de Chine] ; Qi-Hao Guo [République populaire de Chine] ; Adele Dessa Sadovnick [Canada] ; Zhi-Ying Wu [République populaire de Chine] | The LRRK2 R1628P Variant Plays a Protective Role in Han Chinese Population with Alzheimer's Disease |
| 000375 | C. Gibrat [Canada] ; M. Bousquet [Canada] ; M. Saint-Pierre [Canada] ; D. Levesque [Canada] ; F. Calon [Canada] ; C. Rouillard [Canada] ; F. Cicchetti [Canada] | Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor |
| 000594 | Mélanie Bourque [Canada] ; BIN LIU [États-Unis] ; Dean E. Dluzen [États-Unis] ; Therese Di Paolo [Canada] | Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity |
| 000613 | YU YAO [Canada] ; Amandio Vieira [Canada] | Protective activities of Vacciniutn antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity |
| 000701 | Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in Parkinsonian monkeys : Implication of preproenkephalin |
| 000754 | Alan S. Hazell [Canada] ; Louise Normandin [Canada] ; Michael D. Norenberg [États-Unis] ; Gregory Kennedy [Canada] ; Jae-Hyuk Yi [Canada] | Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment |
| 000970 | Nancy Belanger [Canada] ; Laurent Gregoire [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Paul J. Bedard [Canada] | Chronic treatment with small doses of cabergoline prevents Dopa-induced dyskinesias in Parkinsonian monkeys |
| 000A53 | Ali H. Rajput [Canada] | The protective role of levodopa in the human substantia nigra |
| 000B13 | ABDALLAH HADJ TAHAR [Canada] ; Anna Ekesbo [Suède] ; Laurent Gregoire [Canada] ; Evelyne Bangassoro [Canada] ; Kjell A. Svensson [États-Unis] ; Joakim Tedroff [Suède] ; Paul J. Bedard [Canada] | Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys |
| 000B15 | Moussa B. H. Youdim [Israël] ; Edna Grünblatt [Israël] ; Yona Levites-Royak [Israël] ; Silvia Mandel [Israël] | Drugs to prevent cell death in Parkinson's disease: Neuroprotection against oxidative stress and inflammatory gene expression |
| 000C12 | O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada] | A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa |
| 000D60 | C.-T. Lai [Canada] ; P. H. Yu [Canada] | R(-)-deprenyl potentiates dopamine induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells |
| 000E01 | K. Rabheru [Canada] ; E. Persad [Canada] | A review of continuation and maintenance electroconvulsive therapy |
| 000E14 | N. Galvez-Jimenez [Canada] ; A. E. Lang [Canada] | Perioperative problems in Parkinson's disease and their management : Apomorphine with rectal domperidone |
| 000F10 | P. J. Blanchet [Canada] ; R. Boucher [Canada] ; P. J. Bedard | Excitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys |
| 001074 | E. C. Wolters ; T. A. Hurwitz ; E. Mak ; P. Teal ; F. R. Peppard ; R. Remick ; S. Calne ; D. B. Calne | Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis |
| 001135 | T. L. Perry ; VOON WEE YONG ; S. Hansen ; K. Jones ; C. Bergeron ; J. G. Foulks ; J. M. Wright | α-Tocopherol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| This area was generated with Dilib version V0.6.29. |  |